Pranlukast Hydrate 

普仑司特

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NamePranlukast Hydrate 
Drug Alias NameOnon Capsule普伦司特Pranlukastum普仑司特水合物普鲁司特 +[17
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLeukotriene receptor antagonists
TargetsLeukotriene receptor
Therapy Area/IndicationsRhinitis, Allergic, PerennialRhinitis, AllergicAsthma +[4
Global Approved IndicationsRhinitis, AllergicAsthma
Approved Indications in ChinaAsthma
Original Approved Country/TerritoryJapan
Original Approved Date1995/03/31
Country/TerritorySouth KoreaMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesOno Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active IndicationsRhinitis, AllergicAsthma
Inactive IndicationsRhinitis, Allergic, PerennialSinusitis

Other Information

ATC CodeR03DC02